CONDENSED CONSOLIDATED INTERIM STATEMENTS OF LOSS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Apr. 30, 2024	Apr. 30, 2023
EXPENSES
Accretion expense	$ 19,897	$ 41,104	$ 69,419	$ 99,030
Consulting	69,472	186,094	235,655	464,350
Directors' fees	30,000	20,000	88,022	60,000
Filing and regulatory	8,959	13,470	30,545	46,802
Foreign exchange (gain) loss	20,081	(26,781)	27,980	38,699
General and administrative	76,937	147,829	339,088	266,626
Geological, mineral, and prospect costs	337,158	438,319	732,924	675,926
Interest expense	62,569	56,850	192,230	267,028
Professional fees	276,858	181,335	872,136	405,464
Promotion and shareholder communication	8,079	68,947	51,558	154,266
Salaries	(43)	33,750	89,526	101,250
Share-based compensation	0	466,527	230,985	466,527
Loss	(909,967)	(1,627,444)	(2,960,068)	(3,045,968)
Gain (loss) on fair value adjustment on derivative liability	8,742	274,107	137,457	(454,418)
Write-off on receivable	40	0	(64,524)
Other income	8,374	(5)	18,413	1,029
Net loss and comprehensive loss for the period	$ (892,811)	$ (1,353,342)	$ (2,868,722)	$ (3,499,357)
Basic loss per common share	$ (0.02)	$ (0.04)	$ (0.07)	$ (0.09)
Diluted loss per common share	$ (0.02)	$ (0.04)	$ (0.07)	$ (0.09)
Weighted average number of common shares outstanding (basic) (in shares)	47,128,914	39,742,958	43,108,301	34,483,714
Weighted average number of common shares outstanding (diluted) (in shares)	47,128,914	39,742,958	43,108,301	34,483,714